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ABSTRACT: Bryonia epigaea (cucurbitaceae) has been evaluated on various inflammatory 
models in rats in our laboratory.  Ana anti-inflammatory drug(s) irrespective of its potency may 
not be devoid of undesirable effects on biochemical and hematological parameters.  Alcoholic 
extract of Bryonia epigaaea (BE-Extract) at the dose of 50 mg/kg body weight, was administered 
to rats.  Hepatotxic and nephrotoxic effects of BE-Extract were studies by measuring cholesterol, 
urea, uric acid, SGOT, SGPT and glucose levels in blood.  Effects of BE-Extract on RBC count, 
WBC count, platelet count, hemoglobin content, clotting and bleeding time were also studied. 
 
INTRODUCTION 
 
Bryonia epigaea (cucurbitaceae) is known 
as Akasgaddah in Hindi.  It has been used in 
traditional medicine as bitter, alexipharmic, 
emetic and antiinflammatory
1.  The root of 
this creeper is said to possess alternative and 
laxative properties.  It is usually given in 
syphilitic rheumatism and later stages of 
dysentery
1,2.  It is of common occurrence in 
the scrub jungles of South India along the 
hilly tracts.  LD50 value of alcoholic extract 
of Bryonia epigaea (BE-Extract) was found 
to be 1g/kg body weight on Swiss albino 
mice.  We have already reported that BE-
Extract has significant anti-inflammatory, 
analgesic and antispasmogenic activities
3. 
 
The present study deals with the chronic 
toxicity studies of BE-Extracts on hepatic, 
renal and hematological functions in Swiss 
albino rats. 
 
MATERIALS AND METHODS 
 
Dried and milled tubers of Bryonia epigaea 
was macerated with 90% ethniol (72h).  The 
solvent was removed under vacuo and the 
residue was suspended in 
carboxymethylcellolose (CMC).  Healthy 
inbred albino rats (swiss) of either sex 
weighing 150-200 g were selected and 
divided into two groups, each containing  10 
animals for each experiment.  The animals 
were kept under identical laboratory 
condition for one week and were provided 
with normal standard pellet diet and tap 
water ad libitum.  To group I (Control) only 
CMC suspension was given and group II 
received the BE-Extract at the dose of 50 
mg/kg body weight.   After 3 hours, blood 
was collected by cardic puncture in the 
heparinized tube for biochemical studies. 
 
Heparinized whole blood was taken for the 
estimation of cholesterol
4,5, creatinine
4, 
urea
6 and glucose
7,8.  Serum was separated 
from clotted blood for the estimation of uric 
acid
4, serum aspertate aminotransferase 
(SGOT) and serum alanine 
aminotransferasee (SGPT)
9. 
 
For hematological parameters, blood was 
drawn from orbital sinus with the help of a 
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capillary tube and used for the estimation of 
red blood cell (RBC) count
10, white blood 
cell (WBC) count
10, platelet count
11, 
hemoglobin content
10, bleeding time and 
clotting time
11. 
 
The data were statistically analysed by 
students ‘t’ test. 
 
RESULTS 
 
The results have been tabulated in Table 1 
and 2. 
 
HEPATORENAL PARAMETERS 
 
There was insignificant change in 
cholesterol, creatinine urea, uric acid, SGOT 
and SGPT activities in blood of BE-Extract 
treated animals as compared to that of 
control.  It was also observed that when BE-
Extract was administered to alloxan induced 
diabetic rats, glucose level was lowered by 
28% but there was no change in glucose 
level of animals treated with BE-Extract 
alone. 
 
HEMATOLOGICAL PARAMETERS 
 
It was observed that total count of WBC and 
hemoglobin level had decreased 
significantly while clotting time and 
bleeding time had increased in BE-Extract 
treated animals.  There was no appreciable 
change in total count of RBC while platelet 
count decreased. 
 
 
DISCUSSION 
 
The decrease in total count of WBC 
supported the anti-inflammatory activity of 
BE-Extract, as reported earlier 3.  The 
decrease in platelet count, i.e. antiplatelet 
action of anti-inflammatory drugs have been 
advocated by Zucker and Peterson12.   
Increase in clotting time and bleeding time 
after drug administration suggested that BE-
Extract might have anticoagulant property. 
 
Since glucose level was lowered by 28% in 
diabetic rats, it can be concluded that BE-
Extract had hypoglycemic activity in 
diabetic animals only but it didn’t lower the 
normal glucose level. 
 
The insignificant changes in cholesterol, 
creatinine, urea, uric acid, SGOT and SGPT 
levels, indicated that BE-Extract had no 
adverse effects on liver and kidney 
functions. 
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Table-1 Effect of BE-Extract on Hepatorenal parameters. 
 
Parameters Control  Drug  Treated 
Cholesterol (mg/100ml) 
Creatinine (mg/100ml) 
Urea (mg/100ml) 
Uric acid (mg/100ml) 
SGOT (Unit / Litre) 
SGPT (Unit / Litre) 
70.20 ± 1.64 
 1.02 ± 0.08 
25.2 ± 1.72 
2.5 ± 0.44 
86.5 ± 4.6 
65.18 ± 6.82 
73.05 ± 1.72* 
 1.05 ± 0.40* 
27.4 ± 1.86* 
 2.5 ± 0.13* 
82.3 ± 6.2*  
61.62 ± 7.73* 
 
 
 Control  Drug  Treated  Diabetic  Diabetic  & 
Drug treated 
Glucose 
(mg/100ml) 
98.4 + 1.22  97.96 + 1.54  178.43 + 1.73 **  130.0 + 1.04 
 
Each value represents the mean + SEM of ten observations. 
*   Values are insignificant 
** P<0.05, compared to control (students ‘t’ test) 
Pages 25 - 27  4
 
 
Table-2 Effect of BE-Extract on Hematological parameters. 
 
Parameters Control  Drug  Treated 
RBC Count (millions / cmm) 
WBC Count  
Platelet Count 
Hemoglobin content 
(g/100ml whole blood) 
Clotting time (Secs.) 
Bleeding time (Secs.) 
5.67 ± 0.029 
6567 ± 78.90 
377500 ± 11068.67 
 
12.84 ± 0.202 
250 ± 8.198 
187 ± 16.02 
5.24 ± 0.21 ** 
5360 ± 43.01* 
338500 ± 7236** 
 
10.96±0.990** 
350 ± 8.586* 
290 ± 10.78 
 
Each value represents the mean ± SEM of ten observations 
*P<0.001, **P<0.01, Compared to control (Students ‘t’ test) 
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